文献速递神经肿瘤

分子靶向蛋白酶激活探针用于胶质母细胞瘤可视化:与5-氨基乙酰丙酸对比

Molecularly targeted protease-activated probes for visualization of glioblastoma: a comparison with 5-ALA.
PubMed 文献 · J Neurosurg · 2024-03-29

本研究在小鼠原位胶质母细胞瘤模型、体外细胞培养及人胶质母细胞瘤活检组织中,评估了新型近红外蛋白酶激活探针(6QC-ICG、6QC-Cy5、AG2-FNIR、AG2-Cy5)可视化肿瘤组织的能力,并将最有希望的候选探针6QC-ICG与金标准5-氨基乙酰丙酸(5-ALA)进行比较。结果显示6QC-ICG在实验性胶质母细胞瘤中的肿瘤与正常脑组织荧光比值(TNR)高于5-ALA,作者认为6QC-ICG有潜力成为术中荧光成像检测胶质母细胞瘤组织的靶向试剂。

要点

  • 6QC-ICG可被胶质瘤细胞和肿瘤相关巨噬细胞激活,在肿瘤与正常脑组织间产生高对比度。
  • 在实验性胶质母细胞瘤中,6QC-ICG的肿瘤与正常脑组织荧光比值(TNR)高于5-ALA。
  • 近红外荧光探针具有近红外光吸收散射低和组织自发荧光低的优势。

核心结论

  • 半胱氨酸组织蛋白酶可切割探针6QC-ICG被胶质瘤细胞和肿瘤相关巨噬细胞激活,产生高于当前标准5-ALA的肿瘤与正常脑组织对比度。
  • 作者认为6QC-ICG有潜力成为术中荧光成像检测胶质母细胞瘤组织的靶向试剂。

研究设计与样本

  • 将单底物探针6QC-ICG和6QC-Cy5(可被半胱氨酸组织蛋白酶切割)、双底物探针AG2-FNIR和AG2-Cy5(可被半胱氨酸组织蛋白酶和caspase 3切割)以及5-ALA经静脉给予原位肿瘤小鼠。
  • 在体外细胞培养和胶质母细胞瘤患者活检材料离体条件下评估探针激活。
  • 使用临床前和临床可视化平台、荧光分光光度法及共聚焦显微镜定量肿瘤与正常脑组织荧光比值(TNR)并观察荧光团亚细胞定位。

主要发现

  • 体外实验中,单底物探针6QC-ICG在胶质瘤细胞和巨噬细胞中被切割,产生的荧光团在细胞内蓄积。
  • 在实验性胶质母细胞瘤中,单底物和双底物探针均能可视化肿瘤组织,而健康脑组织中信号极低。
  • 6QC-ICG和AG2-FNIR的TNR最高,但6QC-ICG的信号强度更高。
  • 在异种移植和同系小鼠模型以及人胶质母细胞瘤活检材料离体实验中,6QC-ICG能特异性可视化胶质瘤组织。
  • 在同时给予两种化合物的动物中,6QC-ICG在实验性胶质母细胞瘤中的TNR高于5-ALA。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The highly infiltrative growth of glioblastoma (GBM) makes distinction between the tumor and normal brain tissue challenging. Therefore, fluorescence-guided surgery is often used to improve visual identification of radiological tumor margins. The aim of this study was to evaluate the ability of recently developed molecularly targeted near-infrared (NIR) protease-activated probes to visualize GBM tissue and to compare the most promising candidate with the gold standard, 5-aminolevulinic acid (5-ALA). METHODS: Single-substrate probes 6QC-ICG and 6QC-Cy5 (cysteine cathepsin cleavable), double-substrate probes AG2-FNIR and AG2-Cy5 (cysteine cathepsin and caspase 3 cleavable), and 5-ALA were administered intravenously to mice with orthotopic tumors. Activation of the probes was also evaluated in cell cultures in vitro and in biopsy material from patients with GBM ex vivo. The tumor to normal brain tissue fluorescence ratio (TNR) was quantified in brain sections using preclinical and clinical visualization platforms, and in tissue homogenates and cell suspensions using spectrofluorimetry. Subcellular localization of the fluorophores was visualized by confocal microscopy. RESULTS: In vitro, the single-substrate probe 6QC-ICG was cleaved in glioma cells and macrophages, and the resulting fluorophore accumulated intracellularly. In experimental GBMs, both single- and double-substrate probes visualized tumor tissue, while in healthy brain tissue the signal was minimal. TNR was highest for 6QC-ICG and AG2-FNIR, but the signal intensity was higher for 6QC-ICG. Using xenograft and syngeneic mouse models, as well as human GBM biopsy material ex vivo, the authors confirmed the ability of 6QC-ICG to specifically visualize the glioma tissue using preclinical and clinical visualization platforms. Finally, a comparison with 5-ALA in animals coadministered with both compounds revealed a higher TNR for 6QC-ICG in experimental GBMs. CONCLUSIONS: The cysteine cathepsin-cleavable probe 6QC-ICG is activated by glioma cells and tumor-associated macrophages, leading to a high contrast between tumor and nontumorous brain tissue that is superior to that of the current standard, 5-ALA. In addition to a well-defined mechanism of action, protease-activated probes that use NIR fluorophores (e.g., indocyanine green) have the advantage of low absorption and scattering of the NIR light and lower tissue autofluorescence. These results suggest that 6QC-ICG has the potential to become the targeted agent in intraoperative detection of GBM tissue using fluorescence imaging.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Konečná D, Výmola P, Ternerová N, et al. Molecularly targeted protease-activated probes for visualization of glioblastoma: a comparison with 5-ALA. J Neurosurg. 2024. PMID: 38552239. doi:10.3171/2024.1.JNS231137

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。